Adhering to the Barcelona Clinic Liver Cancer Disease Staging and Treatment Algorithm: Disease Burden and Cost of Illness of Hepatocellular Carcinoma in Portugal
HCC's increasing prevalence trend will continue to impose substantial disease burden in terms of premature mortality, with more than 20,000 years of life lost per year in the Portuguese population. Consequently, costs attributed to HCC are expected to rise despite the reduction on mortality by full adherence to the BCLC treatment algorithm. Continuing high disease burden and substantial cost of illness urge for a need of a comprehensive and effective healthcare interventions, as well as adequate resource allocation for HCC.
Authors
- Isabel Monteiro (ORCID: https://orcid.org/0000-0001-9649-3708)
- José Presa (ORCID: https://orcid.org/0000-0003-0861-4296)
- J Félix (ORCID: https://orcid.org/0000-0003-0544-0323)
- Filipe Veloso Gomes (ORCID: https://orcid.org/0000-0002-1435-4665)
- Guilherme Macedo (ORCID: https://orcid.org/0000-0002-9387-9872)
- Joana Alarcão
- Mário Jorge Silva
- Nuno Picado
Institutions
- Hospital de São João (PT)
- Sociedade Portuguesa de Cardiologia (PT)
- Association for the Development of Douro Viticulture (PT)
- Roche (Portugal) (PT)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- GE Portuguese Journal of Gastroenterology
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1159/000542884
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00